People · Operator

Elizabeth Galbut

Named in public records as an officer, director or promoter · active 2020–2025 · Pharmaceuticals, Retailing

2
Companies
5
Filings
$21.3M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Torigen Pharmaceuticals, Inc.PharmaceuticalsSeries A$10.9M$62.1M2020
Future of Latinx Beauty Inc.RetailingSeries A$10.4M$8.5M2025
Operator network

Elizabeth Galbut at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

KEVIN CROWLEY · 9 companies · 1 sharedKEVIN CROWLEYJohn Kallassy · 4 companies · 1 sharedJohn KallassyAshley Kalinauskas · 1 companies · 1 sharedAshley KalinauskasBlake Hawley · 1 companies · 1 sharedBlake HawleyBrad Poff · 1 companies · 1 sharedBrad PoffMark Suckow · 1 companies · 1 sharedMark SuckowMusan Duric · 1 companies · 1 sharedMusan DuricTerry Dew · 1 companies · 1 sharedTerry DewBarbara Canales Rivera · 1 companies · 1 sharedBarbara Canales R…Carl Rivera · 1 companies · 1 sharedCarl RiveraFrancisca Maier · 1 companies · 1 sharedFrancisca MaierRoberta Canales Rivera · 1 companies · 1 sharedRoberta Canales R…Torigen Pharmaceuticals, Inc. · $10.9M raisedTorigen Pharmaceutica…Future of Latinx Beauty Inc. · $10.4M raisedFuture of Latinx Beau…Elizabeth GalbutEG
Elizabeth Galbut Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Elizabeth Galbut on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
KEVIN CROWLEY19
John Kallassy14
Carl Rivera11
Barbara Canales Rivera11
Francisca Maier11
Roberta Canales Rivera11
Blake Hawley11
Musan Duric11
Ashley Kalinauskas11
Mark Suckow11
Brad Poff11
Terry Dew11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.